Page last updated: 2024-10-30

lorazepam and Afferent Pupillary Defect

lorazepam has been researched along with Afferent Pupillary Defect in 2 studies

Lorazepam: A benzodiazepine used as an anti-anxiety agent with few side effects. It also has hypnotic, anticonvulsant, and considerable sedative properties and has been proposed as a preanesthetic agent.

Research Excerpts

ExcerptRelevanceReference
"The patients presented with visual hallucinations, disorientation, incomprehensible and nonsensical speech, and dilated sluggish pupils."1.34Teenagers with Jimson weed (Datura stramonium) poisoning. ( Spina, SP; Taddei, A, 2007)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Agrawal, AK1
Das, S1
Spina, SP1
Taddei, A1

Other Studies

2 other studies available for lorazepam and Afferent Pupillary Defect

ArticleYear
The catatonic pupil: An unprivileged entity.
    Asian journal of psychiatry, 2018, Volume: 32

    Topics: Adult; Antipsychotic Agents; Catatonia; Female; Humans; Lorazepam; Male; Psychotic Disorders; Pupil

2018
Teenagers with Jimson weed (Datura stramonium) poisoning.
    CJEM, 2007, Volume: 9, Issue:6

    Topics: Adolescent; Anti-Anxiety Agents; Antipsychotic Agents; Cholinergic Antagonists; Confusion; Datura st

2007